doi: 10.3389/fimmu.2025.1558414 Received 13 January 2025 Accepted 04 February 2025 Published 21 February 2025 Volume 16 - 2025 Edited by Jin-Yi Wan, Beijing University of Chinese Medicine, China Reviewed by Hui Ye, Peking University, China Ke Xiao, Shandong University, China Weihan Zhao, Shaanxi University of Chinese Medicine, China Updates Copyright 2025 Guan, Cheng, Zhang, Cai, Zhang, Jiang, Wang, Zeng and Jia
At steady state, this sum converges to a predictable range
Diabetologia 53:153159 Nyborg NC, Molck AM, Madsen LW, Knudsen LB (2012) The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species
While more research is needed to confirm its direct benefits for nerve health, current evidence and case reports suggest that it can play an important role when used alongside other therapies
Kohrt advises women in midlife who want to use GLP-1 drugs to lose weight to also think carefully about how weight loss will affect their bone health
They become less bothersome as your body gets used to the medication
